[국제]US FDA approves emergency use of Johnson & Johnson COVID-19 vaccine

Foreign media reported that the US Food and Drug Administration FDA approved the emergency use of Johnson & Johnson’s Corona 19 vaccine on the 27th local time.

The FDA accepted the previous day that the advisory body, the Vaccine and Biological Drugs Advisory Committee, recommended that Johnson & Johnson’s COVID-19 vaccine be approved for emergency use by adults over the age of 19 through a vote.

The remaining steps are discussions by the CDC Advisory Committee of the Centers for Disease Control and Prevention and final approval by the CDC.

The CDC Advisory Committee meets 28 days local time to decide whether to recommend vaccinations.

Upon final approval by the CDC, Johnson & Johnson will be the third COVID-19 vaccine against Americans after Pfizer and Modena.

Johnson & Johnson’s COVID-19 vaccine is reported to have a 66% prevention rate after 4 weeks of vaccination, which is lower than that of Pfizer and Modena vaccines, but it has a serious prevention effect of 85% and is also effective against the South African mutant virus.

It has also been cited as an advantage that it is a single inoculation method and that it can be stored in the refrigerator.

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]

– .